Brief: Scienture Provides Update On The Commercial Launch Of Rezenopy
22/12/2025 13:22
Dec 22 (Reuters) - Scienture Holdings Inc SCNX.O: SCIENTURE PROVIDES UPDATE ON THE COMMERCIAL LAUNCH OF REZENOPY®, THE HIGHEST STRENGTH NALOXONE HCL LIFE-SAVING OPIOID OVERDOSE EMERGENCY TREATMENT APPROVED BY THE FDA SCIENTURE HOLDINGS INC - REZENOPY EXPECTED COMMERCIALLY AVAILABLE EARLY Q2 2026 Source text: ID:nGNX8j4qbF Further company coverage: SCNX.O ((Reuters.Briefs@thomsonreuters.com;))